| Year |
Citation |
Score |
| 2024 |
Ma D, Stocks J, Rosen H, Kantarci K, Lockhart SN, Bateman JR, Craft S, Gurcan MN, Popuri K, Beg MF, Wang L. Differential diagnosis of frontotemporal dementia subtypes with explainable deep learning on structural MRI. Frontiers in Neuroscience. 18: 1331677. PMID 38384484 DOI: 10.3389/fnins.2024.1331677 |
0.538 |
|
| 2024 |
Sachs BC, Latham LA, Bateman JR, Cleveland MJ, Espeland MA, Fischer E, Gaussoin SA, Leng I, Rapp SR, Rogers S, Shappell HM, Williams BJ, Yang M, Craft S. Feasibility of Remote Administration of the Uniform Data Set-Version 3 for Assessment of Older Adults With Mild Cognitive Impairment and Alzheimer's Disease. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 38291734 DOI: 10.1093/arclin/acae001 |
0.316 |
|
| 2023 |
Negrey JD, Frye BM, Johnson CSC, Kim J, Barcus RA, Lockhart SN, Whitlow CT, Sutphen C, Chiou KL, Snyder-Mackler N, Montine TJ, Craft S, Shively CA, Register TC. Mediterranean Diet Protects Against a Neuroinflammatory Cortical Transcriptome: Associations with Brain Volumetrics, Peripheral Inflammation, Social Isolation and Anxiety. Biorxiv : the Preprint Server For Biology. PMID 37961556 DOI: 10.1101/2023.11.01.565068 |
0.567 |
|
| 2023 |
Ong SS, Peavey JJ, Hiatt KD, Whitlow CT, Sappington RM, Thompson AC, Lockhart SN, Chen H, Craft S, Rapp SR, Fitzpatrick AL, Heckbert SR, Luchsinger JA, Klein BEK, Meuer SM, et al. Association of fractal dimension and other retinal vascular network parameters with cognitive performance and neuroimaging biomarkers: The Multi-Ethnic Study of Atherosclerosis (MESA). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37828734 DOI: 10.1002/alz.13498 |
0.577 |
|
| 2023 |
Grayson JM, Short SM, Lee CJ, Park N, Marsac C, Sette A, Lindestam Arlehamn CS, Leng XI, Lockhart SN, Craft S. T cell exhaustion is associated with cognitive status and amyloid accumulation in Alzheimer's disease. Scientific Reports. 13: 15779. PMID 37737298 DOI: 10.1038/s41598-023-42708-8 |
0.615 |
|
| 2023 |
Bhoopal B, Gollapelli KK, Damuka N, Miller M, Krizan I, Bansode A, Register T, Frye BM, Kim J, Mintz A, Orr M, Craft S, Whitlow C, Lockhart SN, Shively C, et al. Preliminary PET Imaging of Microtubule-Based PET Radioligand [C]MPC-6827 in a Nonhuman Primate Model of Alzheimer's Disease. Acs Chemical Neuroscience. PMID 37724996 DOI: 10.1021/acschemneuro.3c00527 |
0.557 |
|
| 2023 |
Bateman JR, Krishnamurthy S, Quillen EE, Waugh CE, Kershaw KN, Lockhart SN, Hughes TM, Seeman TE, Cole SW, Craft S. Social genomics, cognition, and well-being during the COVID-19 pandemic. Medrxiv : the Preprint Server For Health Sciences. PMID 37333113 DOI: 10.1101/2023.05.31.23290618 |
0.579 |
|
| 2023 |
Hanson AJ, Banks WA, Bettcher LF, Pepin R, Raftery D, Navarro SL, Craft S. Cerebrospinal Fluid Metabolomics: Pilot Study of Using Metabolomics to Assess Diet and Metabolic Interventions in Alzheimer's Disease and Mild Cognitive Impairment. Metabolites. 13. PMID 37110227 DOI: 10.3390/metabo13040569 |
0.345 |
|
| 2023 |
Kim D, Lipford ME, He H, Ding Q, Ivanovic V, Lockhart SN, Craft S, Whitlow CT, Jung Y. Parametric cerebral blood flow and arterial transit time mapping using a 3D convolutional neural network. Magnetic Resonance in Medicine. PMID 37092852 DOI: 10.1002/mrm.29674 |
0.488 |
|
| 2023 |
Kumar A, Su Y, Sharma M, Singh S, Kim S, Peavey JJ, Suerken CK, Lockhart SN, Whitlow CT, Craft S, Hughes TM, Deep G. MicroRNA expression in extracellular vesicles as a novel blood-based biomarker for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37071449 DOI: 10.1002/alz.13055 |
0.611 |
|
| 2022 |
Hughes TM, Lockhart SN, Suerken CK, Jung Y, Whitlow CT, Bateman JR, Williams BJ, Espeland MA, Sachs BC, Williamson J, Cleveland M, Yang M, Rogers S, Hayden KM, Baker LD, ... Craft S, et al. Hypertensive Aspects of Cardiometabolic Disorders Are Associated with Lower Brain Microstructure, Perfusion, and Cognition. Journal of Alzheimer's Disease : Jad. PMID 36314205 DOI: 10.3233/JAD-220646 |
0.577 |
|
| 2022 |
Duran T, Bateman JR, Williams BJ, Espeland MA, Hughes TM, Okonmah-Obazee S, Rundle MM, Craft S, Lockhart SN. Neuroimaging and clinical characteristics of cognitive migration in community-dwelling older adults. Neuroimage. Clinical. 36: 103232. PMID 36244197 DOI: 10.1016/j.nicl.2022.103232 |
0.616 |
|
| 2022 |
Kim D, Hughes TM, Lipford ME, Craft S, Baker LD, Lockhart SN, Whitlow CT, Okonmah-Obazee SE, Hugenschmidt CE, Bobinski M, Jung Y. Corrigendum: Relationship between cerebrovascular reactivity and cognition among people with risk of cognitive decline. Frontiers in Physiology. 13: 1020999. PMID 36213243 DOI: 10.3389/fphys.2022.1020999 |
0.602 |
|
| 2022 |
Mahapatra G, Gao Z, Bateman JR, Lockhart SN, Bergstrom J, DeWitt AR, Piloso JE, Kramer PA, Gonzalez-Armenta JL, Amick KA, Casanova R, Craft S, Molina AJA. Blood-based bioenergetic profiling reveals differences in mitochondrial function associated with cognitive performance and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35870133 DOI: 10.1002/alz.12731 |
0.611 |
|
| 2022 |
Coffin C, Suerken CK, Bateman JR, Whitlow CT, Williams BJ, Espeland MA, Sachs BC, Cleveland M, Yang M, Rogers S, Hayden KM, Baker LD, Williamson J, Craft S, Hughes TM, et al. Vascular and microstructural markers of cognitive pathology. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12332. PMID 35814618 DOI: 10.1002/dad2.12332 |
0.588 |
|
| 2022 |
Frye BM, Craft S, Register TC, Kim J, Whitlow CT, Barcus RA, Lockhart SN, Sai KKS, Shively CA. Early Alzheimer's disease-like reductions in gray matter and cognitive function with aging in nonhuman primates. Alzheimer's & Dementia (New York, N. Y.). 8: e12284. PMID 35310523 DOI: 10.1002/trc2.12284 |
0.621 |
|
| 2022 |
Kellar D, Register T, Lockhart SN, Aisen P, Raman R, Rissman RA, Brewer J, Craft S. Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer's disease: a randomized trial. Scientific Reports. 12: 1346. PMID 35079029 DOI: 10.1038/s41598-022-05165-3 |
0.644 |
|
| 2021 |
Lockhart SN, Schaich CL, Craft S, Sachs BC, Rapp SR, Jung Y, Whitlow CT, Solingapuram Sai KK, Cleveland M, Williams BJ, Burke GL, Bertoni A, Hayden KM, Hughes TM. Associations among vascular risk factors, neuroimaging biomarkers, and cognition: Preliminary analyses from the Multi-Ethnic Study of Atherosclerosis (MESA). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34482601 DOI: 10.1002/alz.12429 |
0.571 |
|
| 2021 |
Hoscheidt S, Sanderlin AH, Baker LD, Jung Y, Lockhart S, Kellar D, Whitlow C, Hanson AJ, Friedman S, Register T, Leverenz JB, Craft S. Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid-life: A randomized trial. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34310044 DOI: 10.1002/alz.12421 |
0.618 |
|
| 2021 |
Kim D, Hughes TM, Lipford ME, Craft S, Baker LD, Lockhart SN, Whitlow CT, Okonmah-Obazee SE, Hugenschmidt CE, Bobinski M, Jung Y. Relationship Between Cerebrovascular Reactivity and Cognition Among People With Risk of Cognitive Decline. Frontiers in Physiology. 12: 645342. PMID 34135768 DOI: 10.3389/fphys.2021.645342 |
0.616 |
|
| 2021 |
Kellar D, Lockhart SN, Aisen P, Raman R, Rissman RA, Brewer J, Craft S. Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer's Disease. The Journal of Prevention of Alzheimer's Disease. 8: 240-248. PMID 34101779 DOI: 10.14283/jpad.2021.14 |
0.37 |
|
| 2020 |
Frye BM, Craft S, Register TC, Andrews RN, Appt SE, Vitolins MZ, Uberseder B, Silverstein-Metzler MG, Chen H, Whitlow CT, Kim J, Barcus RA, Lockhart SN, Hoscheidt S, Say BM, et al. Diet, psychosocial stress, and Alzheimer's disease-related neuroanatomy in female nonhuman primates. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33270373 DOI: 10.1002/alz.12232 |
0.575 |
|
| 2020 |
Nagpal R, Neth BJ, Wang S, Mishra SP, Craft S, Yadav H. Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: A pilot study. Ebiomedicine. 59: 102950. PMID 32861197 DOI: 10.1016/J.Ebiom.2020.102950 |
0.422 |
|
| 2020 |
Handing E, Rapp SR, Chen SH, Rejeski J, Wiberg M, Bandeen-Roche K, Craft S, Kitzman D, Ip EH. Heterogeneity in association between cognitive function and gait speed among older adults: An integrative data analysis study. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 32841312 DOI: 10.1093/Gerona/Glaa211 |
0.364 |
|
| 2020 |
Kellar D, Craft S. Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches. The Lancet. Neurology. PMID 32730766 DOI: 10.1016/S1474-4422(20)30231-3 |
0.39 |
|
| 2020 |
Craft S, Raman R, Chow TW, Rafii MS, Sun CK, Rissman RA, Donohue MC, Brewer JB, Jenkins C, Harless K, Gessert D, Aisen PS. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial. Jama Neurology. PMID 32568367 DOI: 10.1001/Jamaneurol.2020.1840 |
0.456 |
|
| 2020 |
Lanctôt KL, Scherer RW, Li A, Vieira D, Coulibaly H, Rosenberg PB, Herrmann N, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, et al. Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 32565008 DOI: 10.1016/J.Jagp.2020.05.020 |
0.311 |
|
| 2020 |
Sachs BC, Steenland K, Zhao L, Hughes TM, Weintraub S, Dodge HH, Barnes LL, Craft S, Parker ML, Goldstein FC. Expanded Demographic Norms for Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set. Alzheimer Disease and Associated Disorders. PMID 32483017 DOI: 10.1097/Wad.0000000000000388 |
0.34 |
|
| 2020 |
Wang X, Zimmermann HR, Lockhart SN, Craft S, Ma T. Decreased Levels of Blood AMPKα1 but not AMPKα2 Isoform in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study. Journal of Alzheimer's Disease : Jad. PMID 32444538 DOI: 10.3233/Jad-191189 |
0.647 |
|
| 2020 |
Craft S, Tripputi M, Edelstein S, Espeland M, Claxton A, Arslanian SA, Barengolts E, Hannon TS, Kahn SE, Mather KJ, Mokhlesi B, Nadeau KJ, Sanderlin A, Temple KA, Zeitler P. 1268-P: Associations between ß-Cell Function and Cognitive Measures following Treatment in Youth with Impaired Glucose Tolerance (IGT) or Recently Diagnosed Type 2 Diabetes (T2D) Diabetes. 69. DOI: 10.2337/Db20-1268-P |
0.388 |
|
| 2020 |
Brinkley T, Lockhart S, Sachs B, Cleveland M, Williams B, Bateman J, Rogers S, Craft S. Adiposity Is Positively Associated With AD-Signature Cortical Thickness in Older Adults Innovation in Aging. 4: 141-141. DOI: 10.1093/geroni/igaa057.462 |
0.604 |
|
| 2020 |
Neyland B, Hugenschmidt C, Lockhart S, Baker L, Craft S, Laurienti P, Kritchevsky S. Brain Resilience: The Effect of White Matter Disease on Brain Networks in Cognitively Normal Older Adults Innovation in Aging. 4: 918-918. DOI: 10.1093/geroni/igaa057.3372 |
0.553 |
|
| 2020 |
Frye B, Craft S, Register T, Kim J, Whitlow C, Lockhart S, Shively C. Mediterranean versus Western diet effects on cerebral cortical thickness and volume in cynomolgus monkeys Innovation in Aging. 4: 489-490. DOI: 10.1093/geroni/igaa057.1583 |
0.571 |
|
| 2019 |
Hanson AJ, Banks WA, Bettcher LF, Pepin R, Raftery D, Craft S. Cerebrospinal fluid lipidomics: effects of an intravenous triglyceride infusion and apoE status. Metabolomics : Official Journal of the Metabolomic Society. 16: 6. PMID 31832778 DOI: 10.1007/S11306-019-1627-X |
0.332 |
|
| 2019 |
Neth BJ, Mintz A, Whitlow C, Jung Y, Solingapuram Sai K, Register TC, Kellar D, Lockhart SN, Hoscheidt S, Maldjian J, Heslegrave AJ, Blennow K, Cunnane SC, Castellano CA, Zetterberg H, ... Craft S, et al. Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study. Neurobiology of Aging. PMID 31757576 DOI: 10.1016/J.Neurobiolaging.2019.09.015 |
0.666 |
|
| 2019 |
Nagpal R, Neth BJ, Wang S, Craft S, Yadav H. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment. Ebiomedicine. PMID 31477562 DOI: 10.1016/J.Ebiom.2019.08.032 |
0.459 |
|
| 2019 |
Mustapic M, Tran J, Craft S, Kapogiannis D. Extracellular Vesicle Biomarkers Track Cognitive Changes Following Intranasal Insulin in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 30958348 DOI: 10.3233/Jad-180578 |
0.394 |
|
| 2019 |
Robertson K, Larson EB, Crane PK, Cholerton B, Craft S, McCormick WC, McCurry SM, Bowen JD, Baker LD, Trittschuh EH. Using Varying Diagnostic Criteria to Examine Mild Cognitive Impairment Prevalence and Predict Dementia Incidence in a Community-Based Sample. Journal of Alzheimer's Disease : Jad. PMID 30909213 DOI: 10.3233/Jad-180746 |
0.391 |
|
| 2019 |
Craft S, Claxton A, Tripputi M, Edelstein S, Arslanian SA, Temple KA, Nadeau KJ, Sanderlin A, Espeland M, Mokhlesi B, Mather KJ, Zeitler P. 1561-P: Associations between ß-Cell Function and Cognitive Measures Differ in Youth vs. Adults with Impaired Glucose Tolerance (IGT) or Early Type 2 Diabetes (T2D) Diabetes. 68. DOI: 10.2337/Db19-1561-P |
0.378 |
|
| 2019 |
El Husseini NK, Schaich CL, Craft S, Rapp S, Fitzpatrick A, Sharrett AR, Klein R, Klein B, Cotch MF, Wong TY, Luchsinger JA, Hughes TM. Abstract WP562: Retinal Vessel Caliber is Associated With Cognitive Function Independent of Cerebrovascular and Renal Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Stroke. 50. DOI: 10.1161/Str.50.Suppl_1.Wp562 |
0.35 |
|
| 2019 |
Sanderlin AH, Baker LD, Hoscheidt SM, Craft S. P4‐679: Ketogenic Dietary Effects On Sleep, Cognition And Behavior In Mci Alzheimers & Dementia. 15: 1592. DOI: 10.1016/J.Jalz.2019.09.044 |
0.309 |
|
| 2019 |
Jung Y, Hughes TM, Lockhart S, Kim D, Whitlow CT, Craft S. P4-575: ARTERIAL STIFFNESS IS ASSOCIATED WITH GREATER WHITE MATTER BLOOD FLOW AND WHITE MATTER HYPERINTENSITIES REGARDLESS OF COGNITIVE STATUS Alzheimer's & Dementia. 15: P1540-P1540. DOI: 10.1016/J.Jalz.2019.08.123 |
0.607 |
|
| 2019 |
Lockhart SN, Craft S, Sachs BC, Rapp SR, Jung Y, Whitlow CT, Solingapuram Sai KK, Hayden KM, Burke GL, Hughes TM. F3-05-03: VASCULAR RISK FACTORS AND MULTIMODAL NEUROIMAGING BIOMARKERS: PRELIMINARY ANALYSES FROM THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) Alzheimer's & Dementia. 15: P870-P871. DOI: 10.1016/J.Jalz.2019.06.4175 |
0.557 |
|
| 2019 |
Lockhart SN, Craft S, Sachs BC, Rapp SR, Jung Y, Whitlow CT, Solingapuram Sai KK, Hayden KM, Burke GL, Hughes TM. IC-P-013: VASCULAR RISK FACTORS AND MULTIMODAL NEUROIMAGING BIOMARKERS: PRELIMINARY ANALYSES FROM THE MULTIETHNIC STUDY OF ATHEROSCLEROSIS (MESA) Alzheimer's & Dementia. 15: P22-P23. DOI: 10.1016/j.jalz.2019.06.4175 |
0.528 |
|
| 2019 |
Kim J, Jung Y, Barcus R, Lockhart SN, Baker LD, Craft S, Whitlow CT. P4-323: MULTI-SCALE ANALYSIS OF WHITE MATTER DEGENERATION IN COGNITIVELY NORMAL AND MCI ADULTS. Alzheimer's & Dementia. 15: P1418-P1419. DOI: 10.1016/J.Jalz.2019.06.3993 |
0.631 |
|
| 2019 |
Kellar DA, Lockhart SN, Neth BJ, Whitlow CT, Jung Y, Craft S. IC-P-156: DIET-RELATED ALTERATIONS IN WHITE MATTER MICROSTRUCTURE IN PARTICIPANTS AT RISK FOR AD Alzheimer's & Dementia. 15: P125-P126. DOI: 10.1016/J.Jalz.2019.06.3435 |
0.601 |
|
| 2019 |
Kellar DA, Lockhart SN, Neth BJ, Whitlow CT, Jung Y, Craft S. P3-401: DIET-RELATED ALTERATIONS IN WHITE MATTER MICROSTRUCTURE IN PARTICIPANTS AT RISK FOR AD Alzheimer's & Dementia. 15: P1106-P1106. DOI: 10.1016/j.jalz.2019.06.3435 |
0.57 |
|
| 2019 |
Sai KKS, Whitlow CT, Kumar JD, Craft S, Mintz A, Macauley-Rambach S. P3-087: In Vivo Evaluations Of Microtubule-Based Pet Radiotracer, [11C]Mpc-6827 In Murine Models Of Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3114 |
0.3 |
|
| 2019 |
Handing EP, Leng XI, Hayden KM, Kritchevsky SB, Craft S. P1-539: Relationship Between Cognitive And Physical Function In Older Adults Across Multiple Studies: A Pooled Analysis Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.1144 |
0.36 |
|
| 2019 |
Sachs BC, Hughes TM, Casanova R, Espeland MA, Fischer E, Hayden KM, Rapp SR, Webb AN, Craft S. P1-469: Algorithmic Identification Of Cognitive Impairment Using The Udsv3 Battery Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.1074 |
0.359 |
|
| 2018 |
Latimer CS, Shively CA, Keene CD, Jorgensen MJ, Andrews RN, Register TC, Montine TJ, Wilson AM, Neth BJ, Mintz A, Maldjian JA, Whitlow CT, Kaplan JR, Craft S. A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30467082 DOI: 10.1016/J.Jalz.2018.06.3057 |
0.348 |
|
| 2018 |
Hughes TM, Wagenknecht LE, Craft S, Mintz A, Heiss G, Palta P, Wong D, Zhou Y, Knopman D, Mosley TH, Gottesman RF. Arterial stiffness and dementia pathology: Atherosclerosis Risk in Communities (ARIC)-PET Study. Neurology. PMID 29549223 DOI: 10.1212/Wnl.0000000000005259 |
0.365 |
|
| 2018 |
Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, Craft S, Gandy S, Buettner C, Stoeckel LE, Holtzman DM, Nathan DM. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nature Reviews. Neurology. PMID 29377010 DOI: 10.1038/Nrneurol.2017.185 |
0.389 |
|
| 2018 |
Scherer RW, Drye L, Mintzer J, Lanctôt K, Rosenberg P, Herrmann N, Padala P, Brawman-Mintzer O, Burke W, Craft S, Lerner AJ, Levey A, Porsteinsson A, van Dyck CH. The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial. Trials. 19: 46. PMID 29347996 DOI: 10.1186/S13063-017-2406-5 |
0.393 |
|
| 2018 |
Hughes TM, Hayden KM, Rapp SR, Baker LD, Sachs BC, Ding J, Craft S, Luchsinger JA, Heckbert S, Post W, Fitzpatrick AL, Burke GL. O3-11-05: Antecedent Vascular Risk Scores And Cognitive Function And Decline: The Multi-Ethnic Study Of Atherosclerosis Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2835 |
0.348 |
|
| 2018 |
Sanderlin AH, Hoscheidt SM, Hanson AJ, Baker LD, Sink KM, Wittmer P, Craft S. P3-019: The Effects Of Diet Intervention On Metabolic Health And Cerebral Spinal Fluid Alzheimer'S Disease Biomarkers: A Randomized Trial Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1374 |
0.317 |
|
| 2017 |
Neth BJ, Craft S. Insulin Resistance and Alzheimer's Disease: Bioenergetic Linkages. Frontiers in Aging Neuroscience. 9: 345. PMID 29163128 DOI: 10.3389/Fnagi.2017.00345 |
0.396 |
|
| 2017 |
Banks WA, Farr SA, Salameh TS, Niehoff ML, Rhea EM, Morley JE, Hanson AJ, Hansen KM, Craft S. Triglycerides cross the blood-brain barrier and induce central leptin and insulin receptor resistance. International Journal of Obesity (2005). PMID 28990588 DOI: 10.1038/Ijo.2017.231 |
0.331 |
|
| 2017 |
Hughes TM, Craft S, Baker LD, Espeland MA, Rapp SR, Sink KM, Bertoni AG, Burke GL, Gottesman RF, Michos ED, Luchsinger JA, Fitzpatrick AL, Hayden KM. Changes in metabolic risk factors over 10 years and their associations with late-life cognitive performance: The Multi-Ethnic Study of Atherosclerosis. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 18-25. PMID 28435852 DOI: 10.1016/J.Dadm.2017.03.003 |
0.353 |
|
| 2017 |
Craft S, Claxton A, Baker LD, Hanson AJ, Cholerton B, Trittschuh EH, Dahl D, Caulder E, Neth B, Montine TJ, Jung Y, Maldjian J, Whitlow C, Friedman S. Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial. Journal of Alzheimer's Disease : Jad. PMID 28372335 DOI: 10.3233/Jad-161256 |
0.465 |
|
| 2017 |
Postupna N, Latimer CS, Larson EB, Sherfield E, Paladin J, Shively CA, Jorgensen MJ, Andrews RN, Kaplan JR, Crane PK, Montine KS, Craft S, Keene CD, Montine TJ. Human Striatal Dopaminergic and Regional Serotonergic Synaptic Degeneration with Lewy Body Disease and Inheritance of APOE ε4. The American Journal of Pathology. PMID 28212814 DOI: 10.1016/J.Ajpath.2016.12.010 |
0.322 |
|
| 2017 |
Jung Y, Johnston ME, Kim J, Whitlow CT, Hughes TM, Baker LD, Craft S. APOE ε4 ALLELE EFFECT ON WHITE AND GRAY MATTER PERFUSION IN COGNITIVELY NORMAL AND MCI GROUPS Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.679 |
0.377 |
|
| 2017 |
Lanctot KL, Scherer R, Li A, Rosenberg PB, Herrmann N, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey AI, Burke WJ, Mintzer JE. MEASURING APATHY IN ALZHEIMER'S DISEASE IN THE APATHY IN DEMENTIA METHYLPHENIDATE TRIAL 2 (ADMET 2): A COMPARISON OF INSTRUMENTS Alzheimer's & Dementia. 13: P184. DOI: 10.1016/J.Jalz.2017.07.038 |
0.354 |
|
| 2017 |
Ding J, Shea S, Post W, Alonso A, Craft S, Burke GL, Rapp SR, Liu Y. Aging-Related Mitochondrial Dysfunction And Cognitive Function: A Transcriptomic Analysis Of Monocytes In A Community-Based Population Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1944 |
0.318 |
|
| 2017 |
Kim J, Barcus R, Jung Y, Baker LD, Craft S, Whitlow CT. Biomechanical Characterization Of Brain Atrophy In Cognitively Normal And Mci Groups Alzheimers & Dementia. 13: 1070. DOI: 10.1016/J.Jalz.2017.06.1533 |
0.38 |
|
| 2016 |
Snyder HM, Ahles T, Calderwood S, Carrillo MC, Chen H, Chang CC, Craft S, De Jager P, Driver JA, Fillet H, Knopman D, Lotze M, Tierney MC, Petanceska S, Saykin A, et al. Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27998721 DOI: 10.1016/J.Jalz.2016.11.002 |
0.327 |
|
| 2016 |
Cholerton B, Baker LD, Montine TJ, Craft S. Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach. Diabetes Spectrum : a Publication of the American Diabetes Association. 29: 210-219. PMID 27899872 DOI: 10.2337/Ds16-0041 |
0.366 |
|
| 2016 |
Snyder HM, Asthana S, Bain L, Brinton R, Craft S, Dubal DB, Espeland MA, Gatz M, Mielke MM, Raber J, Rapp PR, Yaffe K, Carrillo MC. Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27692800 DOI: 10.1016/J.Jalz.2016.08.004 |
0.343 |
|
| 2016 |
Hanson AJ, Banks WA, Hernandez Saucedo H, Craft S. Apolipoprotein E Genotype and Sex Influence Glucose Tolerance in Older Adults: A Cross-Sectional Study. Dementia and Geriatric Cognitive Disorders Extra. 6: 78-89. PMID 27065114 DOI: 10.1159/000444079 |
0.363 |
|
| 2016 |
Sachs BC, Skinner JS, Sink KM, Craft S, Baker LD. High Intensity Aerobic Exercise Improves Performance On Computer Tests Of Executive Function In Adults With Mild Cognitive Impairment: Implications For Cognitive Assessment In Clinical Trials Alzheimers & Dementia. 12: 428. DOI: 10.1016/J.Jalz.2016.06.815 |
0.379 |
|
| 2016 |
Craft S, Neth BJ, Mintz A, Sai K, Shively N, Dahl D, Baker LD, Cunnane S, Register TC, Gage HD. Ketogenic Diet Effects On Brain Ketone Metabolism And Alzheimer'S Disease Csf Biomarkers Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.633 |
0.347 |
|
| 2016 |
Hughes TM, Espeland MA, Sink KM, Baker LD, Craft S, Rapp SR, Fitzpatrick AL, Sharrett AR, Luchsinger JA, Klein R, Klein BE, Wong TY. O2-09-04: Changes in Retinal Signs and their Associations with Cognitive Performance: The Multi-Ethnic Study of Atherosclerosis (MESA) Alzheimer's & Dementia. 12: P248-P248. DOI: 10.1016/J.Jalz.2016.06.445 |
0.322 |
|
| 2016 |
Hughes TM, Baker LD, Bertoni A, Burke GL, Espeland MA, Casanova R, Gottesman RF, Michos ED, Rapp SR, Hayden KM, Sink KM, Craft S. Changes In Metabolic Risk Factors Over 10 Years And Their Associations With Cognitive Performance: The Multi-Ethnic Study Of Atherosclerosis (Mesa) Alzheimers & Dementia. 12: 1119. DOI: 10.1016/J.Jalz.2016.06.2326 |
0.348 |
|
| 2016 |
Neth BJ, Mintz A, Sai K, Gage HD, Shively C, Register TC, Jorgensen MJ, Andrews RN, Atkins HM, Uberseder B, Cline JM, Cunnane S, Castellano C, Keene CD, Montine TJ, ... ... Craft S, et al. Dual-Tracer Acetoacetate And Glucose Metabolism Are Associated With Neuropathologic Amyloid Burden And Alzheimer’S Biomarkers In The Csf Alzheimers & Dementia. 12: 519. DOI: 10.1016/J.Jalz.2016.06.1021 |
0.308 |
|
| 2015 |
Skinner JS, Morgan A, Hernandez-Saucedo H, Hansen A, Corbett S, Arbuckle M, Leverenz JB, Wilkins CH, Craft S, Baker LD. Associations between Markers of Glucose and Insulin Function and Cognitive Function in Healthy African American Elders. Journal of Gerontology & Geriatric Research. 4. PMID 26798567 DOI: 10.4172/2167-7182.1000232 |
0.429 |
|
| 2015 |
Hughes TM, Craft S. The Role of Insulin in the Vascular Contributions to Age-Related Dementia. Biochimica Et Biophysica Acta. PMID 26657615 DOI: 10.1016/J.Bbadis.2015.11.013 |
0.427 |
|
| 2015 |
Sink KM, Craft S, Smith SC, Maldjian JA, Bowden DW, Xu J, Freedman BI, Divers J. Montreal Cognitive Assessment and Modified Mini Mental State Examination in African Americans. Journal of Aging Research. 2015: 872018. PMID 26618003 DOI: 10.1155/2015/872018 |
0.335 |
|
| 2015 |
Espeland MA, Brinton RD, Hugenschmidt C, Manson JE, Craft S, Yaffe K, Weitlauf J, Vaughan L, Johnson KC, Padula CB, Jackson RD, Resnick SM. Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women. Diabetes Care. PMID 26486190 DOI: 10.2337/Dc15-1385 |
0.353 |
|
| 2015 |
Oh ES, Marano CM, Leoutsakos JM, Lee RW, Rissman RA, Smith GS, Craft S, Lyketsos CG. Oral glucose tolerance testing to modulate plasma amyloid levels: A novel biomarker. Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring. 1: 311-315. PMID 26413562 DOI: 10.1016/J.Dadm.2015.06.002 |
0.386 |
|
| 2015 |
Hanson AJ, Bayer JL, Baker LD, Cholerton B, VanFossen B, Trittschuh E, Rissman RA, Donohue MC, Moghadam SH, Plymate SR, Craft S. Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ4 Carriers and Adults with Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. 48: 205-18. PMID 26401941 DOI: 10.3233/Jad-150273 |
0.417 |
|
| 2015 |
Turner RS, Thomas RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, Brewer JB, Rissman RA, Raman R, Aisen PS. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology. PMID 26362286 DOI: 10.1212/Wnl.0000000000002035 |
0.331 |
|
| 2015 |
Hughes TM, Craft S, Lopez OL. Review of 'the potential role of arterial stiffness in the pathogenesis of Alzheimer's disease'. Neurodegenerative Disease Management. 5: 121-35. PMID 25894876 DOI: 10.2217/Nmt.14.53 |
0.346 |
|
| 2015 |
Claxton A, Baker LD, Hanson A, Trittschuh EH, Cholerton B, Morgan A, Callaghan M, Arbuckle M, Behl C, Craft S. Long Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia. Journal of Alzheimer's Disease : Jad. 45: 1269-70. PMID 25869922 DOI: 10.3233/JAD-159002 |
0.36 |
|
| 2015 |
Snyder HM, Corriveau RA, Craft S, Faber JE, Greenberg SM, Knopman D, Lamb BT, Montine TJ, Nedergaard M, Schaffer CB, Schneider JA, Wellington C, Wilcock DM, Zipfel GJ, Zlokovic B, et al. Vascular contributions to cognitive impairment and dementia including Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 710-717. PMID 25510382 DOI: 10.1016/J.Jalz.2014.10.008 |
0.409 |
|
| 2015 |
Claxton A, Baker LD, Hanson A, Trittschuh EH, Cholerton B, Morgan A, Callaghan M, Arbuckle M, Behl C, Craft S. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. Journal of Alzheimer's Disease : Jad. 44: 897-906. PMID 25374101 DOI: 10.3233/Jad-141791 |
0.455 |
|
| 2015 |
Hanson AJ, Craft S, Banks WA. The APOE genotype: modification of therapeutic responses in Alzheimer's disease. Current Pharmaceutical Design. 21: 114-20. PMID 25330331 DOI: 10.2174/1381612820666141020164222 |
0.341 |
|
| 2015 |
Willette AA, Johnson SC, Birdsill AC, Sager MA, Christian B, Baker LD, Craft S, Oh J, Statz E, Hermann BP, Jonaitis EM, Koscik RL, La Rue A, Asthana S, Bendlin BB. Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 504-510.e1. PMID 25043908 DOI: 10.1016/J.Jalz.2014.03.011 |
0.391 |
|
| 2015 |
Chichester L, Wylie AT, Craft S, Kavanagh K. Muscle heat shock protein 70 predicts insulin resistance with aging. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 70: 155-62. PMID 24532784 DOI: 10.1093/Gerona/Glu015 |
0.301 |
|
| 2015 |
Gifford A, Lawrence J, Case D, Rapp S, Baker L, Craft S, Groteluschen DL, Klepin H, Lesser G, Naughton MJ, Sachs B, Samuel TA, Sink K, Williamson J, Shaw EG. Mild cognitive impairment (MCI) in chemotherapy-treated breast cancer survivors. Journal of Clinical Oncology. 33: 9560-9560. DOI: 10.1200/Jco.2015.33.15_Suppl.9560 |
0.375 |
|
| 2015 |
Baker LD, Skinner JS, Craft S, Sink KM, Montine T, Hansen A, Wilson VM, Jung Y, Johnston M, Cholerton B, Callaghan M. Aerobic exercise reduces phosphorylated tau protein in cerebrospinal fluid in older adults with mild cognitive impairment Alzheimers & Dementia. 11: 324. DOI: 10.1016/J.Jalz.2015.07.467 |
0.35 |
|
| 2014 |
Dysken MW, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M, Love S, Schellenberg GD, McCarten JR, Malphurs J, Prieto S, Chen P, Loreck DJ, Trapp G, Bakshi RS, ... ... Craft S, et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. Jama. 311: 33-44. PMID 24381967 DOI: 10.1001/Jama.2013.282834 |
0.33 |
|
| 2014 |
Novak V, Milberg W, Hao Y, Munshi M, Novak P, Galica A, Manor B, Roberson P, Craft S, Abduljalil A. Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes. Diabetes Care. 37: 751-9. PMID 24101698 DOI: 10.2337/Dc13-1672 |
0.374 |
|
| 2014 |
Dysken MW, Guarino PD, Vertrees JE, Asthana S, Sano M, Llorente M, Pallaki M, Love S, Schellenberg GD, McCarten JR, Malphurs J, Prieto S, Chen P, Loreck DJ, Carney S, ... ... Craft S, et al. Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 36-44. PMID 23583234 DOI: 10.1016/J.Jalz.2013.01.014 |
0.353 |
|
| 2014 |
Casanova R, Hsu F, Neth BJ, Sink KM, Rapp S, Williamson J, Espeland MA, Craft S. P2-096: COMBINING STRUCTURAL MRI, PROTEOMIC, AND GENETIC ADNI DATA FOR EARLY DETECTION OF ALZHEIMER'S DISEASE VIA RANDOM FOREST CLASSIFIERS Alzheimer's & Dementia. 10: P506-P506. DOI: 10.1016/J.Jalz.2014.05.770 |
0.307 |
|
| 2014 |
Neth BJ, Casanova R, Hughes T, Craft S. Markers Of Inflammation And Vascular Dysfunction Are Differentially Associated With Hippocampal Volume By Cognitive Status In Adni Alzheimers & Dementia. 10: 90. DOI: 10.1016/J.Jalz.2014.05.165 |
0.402 |
|
| 2014 |
Casanova R, Hsu F, Neth BJ, Sink KM, Rapp SR, Williamson J, Resnick SM, Espeland MA, Craft S. P3-239: RELATIVE IMPACT OF SAMPLE SIZE AND DIMENSIONALITY OF PREDICTORS ON TWO MACHINE LEARNING METHODS FOR DETECTION OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P719-P720. DOI: 10.1016/J.Jalz.2014.05.1330 |
0.318 |
|
| 2014 |
Hughes TM, Craft S, Miller ME, Williamson J, Gerstein H, Markovina S, Murray A, Bryan N, Launer L. Plasma Amylin Levels Are Associated With Brain Structure Among Individuals With Type-2 Diabetes Alzheimers & Dementia. 10: 661. DOI: 10.1016/J.Jalz.2014.05.1179 |
0.381 |
|
| 2014 |
Craft S, Claxton A, Hanson A, Cholerton B, Neth B, Trittschuh E, Baker L. Therapeutic Effects Of Intranasal Insulin And Insulin Analogues On Cognition And Mri Measures In Mild Cognitive Impairment And Alzheimer'S Disease Alzheimers & Dementia. 10: 126. DOI: 10.1016/J.Jalz.2014.04.050 |
0.451 |
|
| 2014 |
Baker LD, Hansen A, Cholerton B, Skinner J, Sink K, Callaghan M, Craft S, Wilson V. Effects Of Aerobic Exercise On Cognition And Biomarkers In Adults With A Double-Hit Risk For Dementia: Mild Cognitive Impairment And Prediabetes Alzheimers & Dementia. 10: 125. DOI: 10.1016/J.Jalz.2014.04.045 |
0.307 |
|
| 2014 |
Hanson AJ, Craft S. The Impact of High Saturated Fat and High Glycemic Index Foods on Cognitive Function and Alzheimer's Disease Biomarkers: Does a Typical Western Diet Cause Alzheimer's Disease?: Does a Typical Western Diet Cause Alzheimer's Disease? Diet and Nutrition in Dementia and Cognitive Decline. 733-742. DOI: 10.1016/B978-0-12-407824-6.00067-7 |
0.397 |
|
| 2013 |
Cholerton B, Baker LD, Craft S. Insulin, cognition, and dementia European Journal of Pharmacology. 719: 170-179. PMID 24070815 DOI: 10.1016/J.Ejphar.2013.08.008 |
0.444 |
|
| 2013 |
Crane PK, Walker R, Hubbard RA, Li G, Nathan DM, Zheng H, Haneuse S, Craft S, Montine TJ, Kahn SE, McCormick W, McCurry SM, Bowen JD, Larson EB. Glucose levels and risk of dementia. The New England Journal of Medicine. 369: 540-8. PMID 23924004 DOI: 10.1056/Nejmoa1215740 |
0.339 |
|
| 2013 |
Hanson AJ, Bayer-Carter JL, Green PS, Montine TJ, Wilkinson CW, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Tsai E, Postupna N, Zhang J, Lampe J, Craft S. Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial. Jama Neurology. 70: 972-80. PMID 23779114 DOI: 10.1001/Jamaneurol.2013.396 |
0.414 |
|
| 2013 |
Freiherr J, Hallschmid M, Frey WH, Brünner YF, Chapman CD, Hölscher C, Craft S, De Felice FG, Benedict C. Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence. Cns Drugs. 27: 505-14. PMID 23719722 DOI: 10.1007/S40263-013-0076-8 |
0.395 |
|
| 2013 |
Friedman SD, Baker LD, Borson S, Jensen JE, Barsness SM, Craft S, Merriam GR, Otto RK, Novotny EJ, Vitiello MV. Growth hormone-releasing hormone effects on brain γ-aminobutyric acid levels in mild cognitive impairment and healthy aging. Jama Neurology. 70: 883-90. PMID 23689947 DOI: 10.1001/Jamaneurol.2013.1425 |
0.401 |
|
| 2013 |
Cholerton B, Larson EB, Baker LD, Craft S, Crane PK, Millard SP, Sonnen JA, Montine TJ. Neuropathologic correlates of cognition in a population-based sample. Journal of Alzheimer's Disease : Jad. 36: 699-709. PMID 23666176 DOI: 10.3233/Jad-130281 |
0.467 |
|
| 2013 |
Claxton A, Baker LD, Wilkinson CW, Trittschuh EH, Chapman D, Watson GS, Cholerton B, Plymate SR, Arbuckle M, Craft S. Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 35: 789-97. PMID 23507773 DOI: 10.3233/Jad-122308 |
0.433 |
|
| 2013 |
Craft S, Cholerton B, Baker LD. Insulin and Alzheimer's disease: Untangling the web Journal of Alzheimer's Disease. 33: S263-S275. PMID 22936011 DOI: 10.3233/Jad-2012-129042 |
0.386 |
|
| 2013 |
Turner R, Craft S, Aisen P. Individuals with Alzheimer's disease exhibit a high prevalence of undiagnosed impaired glucose tolerance and type 2 diabetes mellitus Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.573 |
0.333 |
|
| 2013 |
Hanson A, Saucedo HH, Bartholomew L, Gabriel A, Chapman D, Craft S. APOE genotype and gender influence glucose tolerance in older adults with cognitive impairment Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.1558 |
0.39 |
|
| 2013 |
Claxton A, Baker L, Hanson A, Cholerton B, Trittschuh E, Morgan A, Callaghan M, Arbuckle M, Behl C, Craft S. Long-acting intranasal insulin detemir improves working memory for adults with mild cognitive impairment or early-stage Alzheimer's dementia Alzheimers & Dementia. 9: 657. DOI: 10.1016/J.Jalz.2013.05.1350 |
0.44 |
|
| 2013 |
Baker L, Craft S, Cholerton B, Wilkinson C, Foster-Schubert K, McTiernan A, Williamson J, Sink K, Duncan G. Aerobic exercise effects on cognition in at-risk adults: Role of insulin sensitivity and APOE-ε4 Alzheimers & Dementia. 9: 690. DOI: 10.1016/J.Jalz.2013.04.360 |
0.382 |
|
| 2013 |
Bonner LM, Robinson G, Craft S. Care management for VA patients with vascular risk factors and cognitive impairment: A randomized trial Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.261 |
0.339 |
|
| 2013 |
Sink K, Craft S, Smith C, Maldjian J, Freedman BI, Divers J. O2-04-01: Comparison of Montreal Cognitive Assessment (MoCA) and 3MSE scores in African-Americans Alzheimer's & Dementia. 9: P321-P321. DOI: 10.1016/J.Jalz.2013.04.152 |
0.321 |
|
| 2013 |
Craft S, Claxton A, Baker L, Cholerton B, Hanson A, Callaghan M, Trittschuh E, Arbuckle M. Therapeutic effects of long-acting intranasal insulin detemir for Alzheimer's dementia or mild cognitive impairment Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.084 |
0.457 |
|
| 2013 |
Welsh-Bohmer K, Romero H, Hayden K, Plassman B, Germain C, Sano M, Espeland M, Craft S, Monsch A, Schneider L, Chiang C, Haneline S, Oneil J, Malholtra M, Brannan S, et al. O1-06-01: Challenges in international clinical trials to delay early symptomatic Alzheimer's disease Alzheimer's & Dementia. 9: P137-P138. DOI: 10.1016/J.Jalz.2013.04.079 |
0.304 |
|
| 2012 |
Craft S. Insulin and Alzheimer Disease—Reply Jama Neurology. 69: 670-671. PMID 23753784 DOI: 10.1001/Archneurol.2012.45 |
0.351 |
|
| 2012 |
Cudaback E, Li X, Yang Y, Yoo T, Montine KS, Craft S, Montine TJ, Keene CD. Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation. Journal of Neuroinflammation. 9: 192. PMID 22883744 DOI: 10.1186/1742-2094-9-192 |
0.316 |
|
| 2012 |
Baker LD, Barsness SM, Borson S, Merriam GR, Friedman SD, Craft S, Vitiello MV. Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial. Archives of Neurology. 69: 1420-9. PMID 22869065 DOI: 10.1001/Archneurol.2012.1970 |
0.425 |
|
| 2012 |
Craft S. Alzheimer disease: Insulin resistance and AD--extending the translational path. Nature Reviews. Neurology. 8: 360-2. PMID 22710630 DOI: 10.1038/Nrneurol.2012.112 |
0.379 |
|
| 2012 |
Cholerton B, Baker LD, Trittschuh EH, Crane PK, Larson EB, Arbuckle M, Saucedo HH, McCurry SM, Bowen JD, McCormick WC, Craft S. Insulin and sex interactions in older adults with mild cognitive impairment. Journal of Alzheimer's Disease : Jad. 31: 401-10. PMID 22571978 DOI: 10.3233/Jad-2012-120202 |
0.462 |
|
| 2012 |
Craft S, Foster TC, Landfield PW, Maier SF, Resnick SM, Yaffe K. Session III: Mechanisms of age-related cognitive change and targets for intervention: inflammatory, oxidative, and metabolic processes. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 67: 754-9. PMID 22570133 DOI: 10.1093/Gerona/Gls112 |
0.397 |
|
| 2012 |
Benedict C, Brooks SJ, Kullberg J, Burgos J, Kempton MJ, Nordenskjöld R, Nylander R, Kilander L, Craft S, Larsson EM, Johansson L, Ahlström H, Lind L, Schiöth HB. Impaired insulin sensitivity as indexed by the HOMA score is associated with deficits in verbal fluency and temporal lobe gray matter volume in the elderly. Diabetes Care. 35: 488-94. PMID 22301128 DOI: 10.2337/Dc11-2075 |
0.376 |
|
| 2012 |
Schiöth HB, Craft S, Brooks SJ, Frey WH, Benedict C. Brain insulin signaling and Alzheimer's disease: current evidence and future directions. Molecular Neurobiology. 46: 4-10. PMID 22205300 DOI: 10.1007/S12035-011-8229-6 |
0.375 |
|
| 2012 |
Baker LD, Bayer-Carter JL, Skinner J, Montine TJ, Cholerton BA, Callaghan M, Leverenz JB, Walter BK, Tsai E, Postupna N, Lampe J, Craft S. High-intensity physical activity modulates diet effects on cerebrospinal amyloid-β levels in normal aging and mild cognitive impairment. Journal of Alzheimer's Disease : Jad. 28: 137-46. PMID 21971406 DOI: 10.3233/Jad-2011-111076 |
0.363 |
|
| 2012 |
Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Archives of Neurology. 69: 29-38. PMID 21911655 DOI: 10.1001/Archneurol.2011.233 |
0.468 |
|
| 2012 |
Baker LD, Asthana S, Cholerton BA, Wilkinson CW, Plymate SR, Green PS, Merriam GR, Fishel MA, Watson GS, Cherrier MM, Kletke ML, Mehta PD, Craft S. Cognitive response to estradiol in postmenopausal women is modified by high cortisol. Neurobiology of Aging. 33: 829.e9-20. PMID 21855173 DOI: 10.1016/J.Neurobiolaging.2011.07.002 |
0.336 |
|
| 2012 |
Baker L, Friedman S, Borson S, Barsness S, Craft S, Merriam G, Otto R, Novotny E, Vitiello M. P4-259: Growth hormone-releasing hormone administration in mild cognitive impairment and healthy aging increases inhibitory neurotransmitter activity in brain as measured by MR spectroscopy Alzheimer's & Dementia. 8: S749-S749. DOI: 10.1016/J.Jalz.2013.08.040 |
0.353 |
|
| 2012 |
Claxton A, Wilkinson C, Baker L, Watson G, Bonner LM, Trittschuh E, Callaghan M, Plymate S, Craft S. Intranasal insulin treatment response in Alzheimer's disease influenced by glucose-stimulated insulin secretion Alzheimers & Dementia. 8: 582. DOI: 10.1016/J.Jalz.2012.05.1583 |
0.323 |
|
| 2012 |
Cholerton B, Baker L, Trittschuh E, Larson E, Crane P, McCurry S, McCormick W, Bowen J, Saucedo HH, Arbuckle M, Craft S. P3-078: Mild cognitive impairment: Classification methods and two-year dementia conversion rates Alzheimer's & Dementia. 8: P480-P480. DOI: 10.1016/J.Jalz.2012.05.1297 |
0.393 |
|
| 2012 |
Hanson A, Baker L, Callaghan M, Cholerton B, Bayer-Carter J, Craft S. Influence of diet macronutrients on cognition and the interaction with ApoE ɛ4 genotype Alzheimers & Dementia. 8: 388. DOI: 10.1016/J.Jalz.2012.05.1073 |
0.354 |
|
| 2011 |
Cholerton B, Baker LD, Craft S. Insulin resistance and pathological brain ageing Diabetic Medicine. 28: 1463-1475. PMID 21974744 DOI: 10.1111/J.1464-5491.2011.03464.X |
0.397 |
|
| 2011 |
Breitner JC, Baker LD, Montine TJ, Meinert CL, Lyketsos CG, Ashe KH, Brandt J, Craft S, Evans DE, Green RC, Ismail MS, Martin BK, Mullan MJ, Sabbagh M, Tariot PN, et al. Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 402-11. PMID 21784351 DOI: 10.1016/J.Jalz.2010.12.014 |
0.385 |
|
| 2011 |
Wharton W, Baker LD, Gleason CE, Dowling M, Barnet JH, Johnson S, Carlsson C, Craft S, Asthana S. Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: Results of a randomized controlled trial Journal of Alzheimer's Disease. 26: 495-505. PMID 21694454 DOI: 10.3233/Jad-2011-110341 |
0.39 |
|
| 2011 |
Bayer-Carter JL, Green PS, Montine TJ, VanFossen B, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Walter BK, Tsai E, Plymate SR, Postupna N, Wilkinson CW, Zhang J, ... ... Craft S, et al. Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Archives of Neurology. 68: 743-52. PMID 21670398 DOI: 10.1001/Archneurol.2011.125 |
0.389 |
|
| 2011 |
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 280-92. PMID 21514248 DOI: 10.1016/J.Jalz.2011.03.003 |
0.415 |
|
| 2011 |
Trittschuh EH, Crane PK, Larson EB, Cholerton B, McCormick WC, McCurry SM, Bowen JD, Baker LD, Craft S. Effects of varying diagnostic criteria on prevalence of mild cognitive impairment in a community based sample. Journal of Alzheimer's Disease : Jad. 25: 163-73. PMID 21368379 DOI: 10.3233/Jad-2011-101821 |
0.372 |
|
| 2011 |
Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Archives of Neurology. 68: 51-7. PMID 20837822 DOI: 10.1001/Archneurol.2010.225 |
0.399 |
|
| 2011 |
Claxton A, Watson GS, Baker L, Craft S. Gender differences in cognitive benefits of intranasal insulin Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.2238 |
0.399 |
|
| 2010 |
Suzuki R, Lee K, Jing E, Biddinger SB, McDonald JG, Montine TJ, Craft S, Kahn CR. Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metabolism. 12: 567-79. PMID 21109190 DOI: 10.1016/J.Cmet.2010.11.006 |
0.305 |
|
| 2010 |
Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkinson CW, McTiernan A, Cholerton BA, Plymate SR, Fishel MA, Watson GS, Duncan GE, Mehta PD, Craft S. Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 22: 569-79. PMID 20847403 DOI: 10.3233/Jad-2010-100768 |
0.426 |
|
| 2010 |
Montine TJ, Shi M, Quinn JF, Peskind ER, Craft S, Ginghina C, Chung KA, Kim H, Galasko DR, Jankovic J, Zabetian CP, Leverenz JB, Zhang J. CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2682-5. PMID 20818673 DOI: 10.1002/Mds.23287 |
0.312 |
|
| 2010 |
Gold M, Alderton C, Zvartau-Hind M, Egginton S, Saunders AM, Irizarry M, Craft S, Landreth G, Linnamägi U, Sawchak S. Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study. Dementia and Geriatric Cognitive Disorders. 30: 131-46. PMID 20733306 DOI: 10.1159/000318845 |
0.369 |
|
| 2010 |
VanFossen BT, Watson GS, Baker LD, Rhoads KW, Cholerton BA, Reger MA, Plymate SR, Schellenberg G, Craft S. Statin users without an APOE-epsilon4 allele have increased insulin resistance. Journal of Alzheimer's Disease : Jad. 19: 1149-53. PMID 20308781 DOI: 10.3233/Jad-2010-1319 |
0.309 |
|
| 2010 |
Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkinson CW, McTiernan A, Plymate SR, Fishel MA, Watson GS, Cholerton BA, Duncan GE, Mehta PD, Craft S. Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Archives of Neurology. 67: 71-9. PMID 20065132 DOI: 10.1001/Archneurol.2009.307 |
0.411 |
|
| 2010 |
Craft S, Baker LD, Montine TJ, Zhang J, Watson GS, Plymate S, Tsai E, Callaghan M, Leverenz J, Gerton B, Trittschuh E. O4-08-01: Intranasal Insulin- And Biomarker-associated Improvement in Memory and Functional Status in Mild Cognitive Impairment and Alzheimer's Disease: Results of a Randomized, Double-blind, Placebo-controlled Pilot Trial Alzheimer's & Dementia. 6: e18-e18. DOI: 10.1016/J.Jalz.2010.08.054 |
0.43 |
|
| 2010 |
Carter JL, Craft S, VanFossen B, Green PS, Baker LD, Wilkinson CW, Montine T, Watson GS, Bonner L, Plymate S, Tsai E, Callaghan M, Leverenz J, Gerton B, Kahn SE. O4-06-06: Modulating dietary fat and glycemic load affects CSF biomarkers and cognition in adults with MCI: The role of the Western diet in the pathophysiology of Alzheimer's disease Alzheimer's & Dementia. 6: S161-S161. DOI: 10.1016/J.Jalz.2010.05.501 |
0.399 |
|
| 2010 |
Craft S, Baker LD, Green PS, Minoshima S, Cross D, Montine TJ, Watson GS, Van Fossen B, Bonner L, Wilkinson CW, Plymate SR, Tsai E, Callaghan M, Leverenz J, Gerton B, et al. P3-455: A randomized, placebo-controlled trial of intranasal insulin in amnestic MCI and early Alzheimer's Alzheimer's & Dementia. 6: S587-S587. DOI: 10.1016/J.Jalz.2010.05.1998 |
0.367 |
|
| 2010 |
Haan MN, Green P, Craft S, Al-Hazzouri AZ, Whitmer R. P3-071: Dementia and type 2 diabetes: The role of body composition and insulin degrading enzyme Alzheimer's & Dementia. 6: S470-S470. DOI: 10.1016/J.Jalz.2010.05.1565 |
0.305 |
|
| 2010 |
Watson GS, Bonner L, Baker LD, Arbuckle M, VanFossen BT, Cholerton BA, Reger MA, Rhoads KW, Plymate SR, Asthana S, Craft S. Blood pressure moderates insulin-induced memory facilitation in older adults with and without memory impairments Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1395 |
0.308 |
|
| 2009 |
Sonnen JA, Larson EB, Haneuse S, Woltjer R, Li G, Crane PK, Craft S, Montine TJ. Neuropathology in the adult changes in thought study: a review. Journal of Alzheimer's Disease : Jad. 18: 703-11. PMID 19661627 DOI: 10.3233/Jad-2009-1180 |
0.447 |
|
| 2009 |
Watson GS, Baker LD, Cholerton BA, Rhoads KW, Merriam GR, Schellenberg GD, Asthana S, Cherrier M, Craft S. Effects of insulin and octreotide on memory and growth hormone in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 18: 595-602. PMID 19625744 DOI: 10.3233/Jad-2009-1165 |
0.398 |
|
| 2009 |
Carrillo MC, Blackwell A, Hampel H, Lindborg J, Sperling R, Schenk D, Sevigny JJ, Ferris S, Bennett DA, Craft S, Hsu T, Klunk W. Early risk assessment for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 182-96. PMID 19328456 DOI: 10.1016/J.Jalz.2009.01.019 |
0.343 |
|
| 2009 |
Craft S. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Archives of Neurology. 66: 300-5. PMID 19273747 DOI: 10.1001/Archneurol.2009.27 |
0.351 |
|
| 2009 |
Sonnen JA, Larson EB, Brickell K, Crane PK, Woltjer R, Montine TJ, Craft S. Different patterns of cerebral injury in dementia with or without diabetes. Archives of Neurology. 66: 315-22. PMID 19139294 DOI: 10.1001/Archneurol.2008.579 |
0.371 |
|
| 2009 |
Craft S. Insulin resistance and Alzheimer's disease: Untangling the web Alzheimers & Dementia. 5: 142. DOI: 10.1016/J.Jalz.2009.05.482 |
0.345 |
|
| 2009 |
Gold M, Alderton C, Zvartau-Hind M, Ritchie S, Saunders A, Craft S, Landreth G, Linnamägi Ü, Sawchak S. Effects of rosiglitazone as monotherapy in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease Alzheimers & Dementia. 5: 86. DOI: 10.1016/J.Jalz.2009.05.219 |
0.351 |
|
| 2009 |
Alderton C, Zvartau-Hind M, Ritchie S, Saunders A, Craft S, Landreth G, Linnamägi Ü, Sawchak S, Gold M. Secondary endpoint and responder analyses in a study of rosiglitazone XR in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease Alzheimers & Dementia. 5: 254. DOI: 10.1016/J.Jalz.2009.04.271 |
0.357 |
|
| 2009 |
Zvartau-Hind M, Alderton C, Ritchie S, Saunders A, Irizarry M, Craft S, Landreth G, Linnamägi Ü, Sawchak S, Gold M. Safety and tolerability of rosiglitazone XR in a randomised, placebo-controlled study in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease Alzheimers & Dementia. 5: 248. DOI: 10.1016/J.Jalz.2009.04.252 |
0.323 |
|
| 2008 |
Martin BK, Szekely C, Brandt J, Piantadosi S, Breitner JC, Craft S, Evans D, Green R, Mullan M. Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib. Archives of Neurology. 65: 896-905. PMID 18474729 DOI: 10.1001/Archneur.2008.65.7.Nct70006 |
0.425 |
|
| 2008 |
Reger MA, Watson GS, Green PS, Baker LD, Cholerton B, Fishel MA, Plymate SR, Cherrier MM, Schellenberg GD, Frey WH, Craft S. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. Journal of Alzheimer's Disease : Jad. 13: 323-31. PMID 18430999 DOI: 10.3233/Jad-2008-13309 |
0.413 |
|
| 2008 |
Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B, Fishel MA, Plymate SR, Breitner JC, DeGroodt W, Mehta P, Craft S. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology. 70: 440-8. PMID 17942819 DOI: 10.1212/01.Wnl.0000265401.62434.36 |
0.425 |
|
| 2008 |
Watson GS, Craft S. Insulin resistance Alzheimer's disease: Pathophysiology and treatment Progress in Neurotherapeutics and Neuropsychopharmacology. 3: 85-110. DOI: 10.1017/S1748232107000031 |
0.399 |
|
| 2008 |
Craft S. S5-01-04: Insulin and Alzheimer's disease therapeutics Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.561 |
0.356 |
|
| 2008 |
Larson EB, Crane P, McCurry SM, Bowen JD, McCormick WC, Teri L, Montine TJ, Craft S, Sonnen JA, Cholerton BA, Breitner JC. P4-034: Seattle adult changes in thought (ACT) study: A population-based “living laboratory” to study dementia and aging Alzheimer's & Dementia. 4: T677-T678. DOI: 10.1016/J.Jalz.2008.05.2098 |
0.311 |
|
| 2007 |
Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD, Craft S, Leverenz JB, Montine TJ. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Annals of Neurology. 62: 406-13. PMID 17879383 DOI: 10.1002/Ana.21208 |
0.379 |
|
| 2007 |
Craft S. Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Current Alzheimer Research. 4: 147-52. PMID 17430239 DOI: 10.2174/156720507780362137 |
0.398 |
|
| 2007 |
Cherrier MM, Matsumoto AM, Amory JK, Johnson M, Craft S, Peskind ER, Raskind MA. Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men Psychoneuroendocrinology. 32: 72-79. PMID 17145137 DOI: 10.1016/J.Psyneuen.2006.10.008 |
0.364 |
|
| 2007 |
Craft S, Peskind E, Goldgaber D, Li G, Nie W, Galasko D, Leverenz J, Petrie E, Raskind M. P-027: CSF transthyretin levels are associated with APOE genotype and CSF aβ42 in AD Alzheimers & Dementia. 3. DOI: 10.1016/J.Jalz.2007.04.243 |
0.326 |
|
| 2007 |
VanFossen BT, Watson GS, Baker LD, Rhoads KW, Cholerton BA, Reger MA, Fishel MA, Plymate SR, Schellenberg GD, Craft S. P-184: APOE-e4 carriers treated with statins have greater insulin-mediated glucose disposal Alzheimers & Dementia. 3. DOI: 10.1016/J.Jalz.2007.04.147 |
0.311 |
|
| 2007 |
Baker LD, Asthana S, Craft S, Cholerton B, Merriam G, Wilkinson CW, Plymate SR, Fishel M, Green PS, Watson GS, Reger MA. P-151: Co-administration of estradiol and cortisol modulates beta-amyloid, IGF activity, and cognitive function for older postmenopausal women Alzheimers & Dementia. 3. DOI: 10.1016/J.Jalz.2007.04.114 |
0.355 |
|
| 2006 |
Reger MA, Craft S. Intranasal insulin administration: a method for dissociating central and peripheral effects of insulin. Drugs of Today (Barcelona, Spain : 1998). 42: 729-39. PMID 17171192 DOI: 10.1358/Dot.2006.42.11.1007675 |
0.337 |
|
| 2006 |
Craft S. Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications. Alzheimer Disease & Associated Disorders. 20: 298-301. PMID 17132977 DOI: 10.1097/01.Wad.0000213866.86934.7E |
0.344 |
|
| 2006 |
Kulstad JJ, Green PS, Cook DG, Watson GS, Reger MA, Baker LD, Plymate SR, Asthana S, Rhoads K, Mehta PD, Craft S. Differential modulation of plasma beta-amyloid by insulin in patients with Alzheimer disease. Neurology. 66: 1506-10. PMID 16717209 DOI: 10.1212/01.Wnl.0000216274.58185.09 |
0.375 |
|
| 2006 |
Watson GS, Craft S. Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis. Journal of the Neurological Sciences. 245: 21-33. PMID 16631207 DOI: 10.1016/J.Jns.2005.08.017 |
0.39 |
|
| 2006 |
Pedersen WA, McMillan PJ, Kulstad JJ, Leverenz JB, Craft S, Haynatzki GR. Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Experimental Neurology. 199: 265-73. PMID 16515786 DOI: 10.1016/J.Expneurol.2006.01.018 |
0.311 |
|
| 2006 |
Risner ME, Saunders AM, Altman JF, Ormandy GC, Craft S, Foley IM, Zvartau-Hind ME, Hosford DA, Roses AD. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. The Pharmacogenomics Journal. 6: 246-54. PMID 16446752 DOI: 10.1038/Sj.Tpj.6500369 |
0.396 |
|
| 2006 |
Watson GS, Reger MA, Baker LD, McNeely MJ, Fujimoto WY, Kahn SE, Boyko EJ, Leonetti DL, Craft S. Effects of exercise and nutrition on memory in Japanese Americans with impaired glucose tolerance. Diabetes Care. 29: 135-6. PMID 16373910 DOI: 10.2337/Diacare.29.01.06.Dc05-1889 |
0.333 |
|
| 2006 |
Watson GS, Bernhardt T, Reger MA, Cholerton BA, Baker LD, Peskind ER, Asthana S, Plymate SR, Frölich L, Craft S. Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease. Neurobiology of Aging. 27: 38-41. PMID 16298239 DOI: 10.1016/J.Neurobiolaging.2004.11.011 |
0.432 |
|
| 2006 |
Li G, Cherrier MM, Tsuang DW, Petrie EC, Colasurdo EA, Craft S, Schellenberg GD, Peskind ER, Raskind MA, Wilkinson CW. Salivary cortisol and memory function in human aging. Neurobiology of Aging. 27: 1705-14. PMID 16274857 DOI: 10.1016/J.Neurobiolaging.2005.09.031 |
0.362 |
|
| 2006 |
Reger MA, Watson GS, Frey WH, Baker LD, Cholerton B, Keeling ML, Belongia DA, Fishel MA, Plymate SR, Schellenberg GD, Cherrier MM, Craft S. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiology of Aging. 27: 451-8. PMID 15964100 DOI: 10.1016/J.Neurobiolaging.2005.03.016 |
0.39 |
|
| 2006 |
Lockhart SN, Hoscheidt SM, Fatima H, Sanderlin AH, Whitlow CT, Jung Y, Craft S. IC-P-100: USING MULTIMODAL IMAGING BIOMARKERS TO PREDICT COGNITIVE STATUS IN A COMMUNITY-DWELLING OLDER ADULT COHORT Alzheimer's & Dementia. 14: P86-P86. DOI: 10.1016/J.Jalz.2018.06.2164 |
0.612 |
|
| 2006 |
Fatima H, Hoscheidt SM, Lockhart SN, Whitlow CT, Jung Y, Dahl D, Craft S. P2-443: INVESTIGATING THE IMPACTS OF DIABETIC STATUS AND COGNITIVE DIAGNOSIS ON AD SIGNATURE CORTICAL THICKNESS Alzheimer's & Dementia. 14: P885-P886. DOI: 10.1016/J.Jalz.2018.06.1135 |
0.637 |
|
| 2006 |
Latimer CS, Shively CA, Keene D, Jorgensen MJ, Andrews RN, Register TC, Montine TJ, Wilson A, Neth BJ, Mintz A, Maldjian J, Whitlow CT, Kaplan JR, Craft S. P1-105: A NON-HUMAN PRIMATE MODEL OF EARLY ALZHEIMER'S DISEASE PATHOLOGIC CHANGE Alzheimer's & Dementia. 14: P311-P312. DOI: 10.1016/J.Jalz.2018.06.108 |
0.336 |
|
| 2006 |
Lockhart SN, Hoscheidt SM, Fatima H, Sanderlin AH, Whitlow CT, Jung Y, Craft S. P2-356: USING MULTIMODAL IMAGING BIOMARKERS TO PREDICT COGNITIVE STATUS IN A COMMUNITY-DWELLING OLDER ADULT COHORT Alzheimer's & Dementia. 14: P825-P826. DOI: 10.1016/j.jalz.2018.06.1047 |
0.579 |
|
| 2006 |
Marques MA, Cook DG, Craft S. P1-394: Increased plasma retinol binding protein 4 levels in insulin-resistant adults with Alzheimer’s disease Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.772 |
0.315 |
|
| 2006 |
Craft S, Reger M, Baker LD, Watson GS, Fishel M, Cholerton B, Green P, Breitner JC, DeGroodt W, Frey WH. O3-05-05: Therapeutic effects of daily intranasal insulin administration in early Alzheimer's disease Alzheimer's & Dementia. 2: S63-S63. DOI: 10.1016/J.Jalz.2006.05.227 |
0.35 |
|
| 2006 |
Watson GS, Rhoads KW, Cholerton BA, Baker LD, Reger MA, Green PS, Kulstad JJ, Cook DG, Schellenberg GD, Fishel MA, Plymate SR, Asthana S, Cherrier MM, Craft S. P4-341: Effects of insulin and octreotide on memory in Alzheimer’s disease and healthy aging Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.2082 |
0.34 |
|
| 2006 |
Zvartau-Hind ME, Hosford DA, Saunders AM, Risner ME, Ormandy GC, Craft S, Altman JF, Foley I, Roses AD. P2-397: Safety and tolerability of rosiglitazone (RSG) in patients with mild to moderate Alzheimer's disease (AD) Alzheimer's & Dementia. 2: S362-S363. DOI: 10.1016/J.Jalz.2006.05.1236 |
0.364 |
|
| 2006 |
Baker LD, Minoshima S, Cross D, Belongia D, Watson GS, Craft S. P2-224: Regional overlap of cerebral glucose metabolism at rest and during list learning for older insulin resistant and Alzheimer adults Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1063 |
0.341 |
|
| 2006 |
Hale C, Baker LD, Cholerton B, Watson GS, Craft S. P2-192: Episodic memory profile for amnestic mild cognitive impairment Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1030 |
0.386 |
|
| 2006 |
LoGalbo A, Baker L, Craft S. P2-188: Prediction of cognitive impairment among elderly persons using a brief cognitive screening battery Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1026 |
0.389 |
|
| 2005 |
Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, Fishel MA, Kulstad JJ, Green PS, Cook DG, Kahn SE, Keeling ML, Craft S. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 13: 950-8. PMID 16286438 DOI: 10.1176/appi.ajgp.13.11.950 |
0.357 |
|
| 2005 |
Craft S. Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiology of Aging. 26: 65-69. PMID 16266773 DOI: 10.1016/J.Neurobiolaging.2005.08.021 |
0.384 |
|
| 2005 |
Fishel MA, Watson GS, Montine TJ, Wang Q, Green PS, Kulstad JJ, Cook DG, Peskind ER, Baker LD, Goldgaber D, Nie W, Asthana S, Plymate SR, Schwartz MW, Craft S. Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults. Archives of Neurology. 62: 1539-44. PMID 16216936 DOI: 10.1001/Archneur.62.10.Noc50112 |
0.366 |
|
| 2005 |
Craft S. Insulin Resistance and Cognitive Impairment: A View Through the Prism of Epidemiology Jama Neurology. 62: 1043-1044. PMID 16009754 DOI: 10.1001/Archneur.62.7.1043-A |
0.393 |
|
| 2005 |
Cherrier MM, Matsumoto AM, Amory JK, Asthana S, Bremner W, Peskind ER, Raskind MA, Craft S. Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment Neurology. 64: 2063-2068. PMID 15985573 DOI: 10.1212/01.Wnl.0000165995.98986.F1 |
0.45 |
|
| 2005 |
Kulstad JJ, McMillan PJ, Leverenz JB, Cook DG, Green PS, Peskind ER, Wilkinson CW, Farris W, Mehta PD, Craft S. Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque. Journal of Neuropathology and Experimental Neurology. 64: 139-46. PMID 15751228 DOI: 10.1093/Jnen/64.2.139 |
0.327 |
|
| 2005 |
Cherrier MM, Matsumoto AM, Amory JK, Ahmed S, Bremner W, Peskind ER, Raskind MA, Johnson M, Craft S. The role of aromatization in testosterone supplementation: Effects on cognition in older men Neurology. 64: 290-296. PMID 15668427 DOI: 10.1212/01.Wnl.0000149639.25136.Ca |
0.353 |
|
| 2005 |
Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, Fishel MA, Kulstad JJ, Green PS, Cook DG, Kahn SE, Keeling ML, Craft S. Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone American Journal of Geriatric Psychiatry. 13: 950-958. DOI: 10.1097/00019442-200511000-00005 |
0.47 |
|
| 2005 |
Craft S, Reger M, Watson GS, Plymate S, Fishel M, Frey W, Baker L, Cholerton B, Rhoads K. Therapeutic effects of intranasal insulin in patients with AD and amnestic MCI Alzheimers & Dementia. 1. DOI: 10.1016/J.Jalz.2005.06.333 |
0.369 |
|
| 2004 |
Burkhardt MS, Foster JK, Laws SM, Baker LD, Craft S, Gandy SE, Stuckey BG, Clarnette R, Nolan D, Hewson-Bower B, Martins RN. Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4. Journal of Alzheimer's Disease : Jad. 6: 221-8. PMID 15201477 DOI: 10.3233/Jad-2004-6302 |
0.365 |
|
| 2004 |
Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, Hyde K, Chapman D, Craft S. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiology of Aging. 25: 311-4. PMID 15123336 DOI: 10.1016/S0197-4580(03)00087-3 |
0.397 |
|
| 2004 |
Watson GS, Craft S. Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease. European Journal of Pharmacology. 490: 97-113. PMID 15094077 DOI: 10.1016/J.Ejphar.2004.02.048 |
0.394 |
|
| 2004 |
Craft S, Watson GS. Insulin and neurodegenerative disease: shared and specific mechanisms. The Lancet. Neurology. 3: 169-78. PMID 14980532 DOI: 10.1016/S1474-4422(04)00681-7 |
0.366 |
|
| 2004 |
Reger MA, Welsh RK, Watson GS, Cholerton B, Baker LD, Craft S. The relationship between neuropsychological functioning and driving ability in dementia: a meta-analysis. Neuropsychology. 18: 85-93. PMID 14744191 DOI: 10.1037/0894-4105.18.1.85 |
0.439 |
|
| 2004 |
Cherrier MM, Plymate S, Mohan S, Asthana S, Matsumoto AM, Bremner W, Peskind E, Raskind M, Latendresse S, Haley AP, Craft S. Relationship between testosterone supplementation and insulin-like growth factor-I levels and cognition in healthy older men. Psychoneuroendocrinology. 29: 65-82. PMID 14575730 DOI: 10.1016/S0306-4530(02)00136-1 |
0.376 |
|
| 2004 |
McMillan PJ, Leverenz JB, Bird TD, Schellenberg GD, Craft S. P4-285 Insulin degrading enzyme immunostaining is decreased in the hippocampus of familial Alzheimer's disease subjects with presenilin 1 mutations Neurobiology of Aging. 25: S556. DOI: 10.1016/S0197-4580(04)81843-8 |
0.325 |
|
| 2004 |
Kulstad J, Green PS, Cook DG, Watson GS, Reger M, Cholerton B, Baker LD, Plymate SR, Asthana S, Fishel M, Kahn SE, Craft S. P3-012 Effects of rosiglitazone treatment on serum amyloid-beta 1–40 and 1–42 in patients with early Alzheimer's disease Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81167-9 |
0.32 |
|
| 2004 |
Hale C, Baker LD, Reger M, Rhoads K, Cholerton B, Watson GS, Craft S. P2-369 Agraphic changes in mild cognitive impairment Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81112-6 |
0.396 |
|
| 2004 |
Slattery AM, Ohrt TL, Gleason CE, Helmers JR, Cholerton B, Lofgreen C, Baker LD, Craft S, Asthana S. P2-352 Alzheimer's disease: potential beneficial effects of estrogen on performance-based battery of physical function skills for older women Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81095-9 |
0.336 |
|
| 2004 |
Lane NJ, Baker LD, Gleason CE, Koscik R, Cholerton B, Craft S, Slattery AM, Ohrt TL, Asthana S. P1-425 Raloxifene enhances cognitive function for postmenopausal women with Alzheimer's disease Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80737-1 |
0.406 |
|
| 2004 |
Reger M, Watson GS, Cholerton B, Baker LD, Asthana S, Plymate S, Wilkinson CW, Peskind ER, Enstrom K, Hyde K, Belongia D, Craft S. P1-255 Cortisol infusion attenuates insulin's facilitation of verbal memory in patients with Alzheimer's disease Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80568-2 |
0.369 |
|
| 2004 |
Baker LD, Cholerton B, Reger M, Watson S, Chapman D, Enstrom K, Hyde K, Craft S. P1-056 Hyperinsulinemia predicts cognitive performance for normal older adults and for patients with Alzheimer's disease Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80370-1 |
0.414 |
|
| 2004 |
Watson GS, Reger MA, Cholerton BA, Asthana S, Baker LD, Rhoads KW, Plymate SR, Fishel MA, Kahn SE, Craft S. O4-05-05 Rosiglitazone preserves cognitive functions in patients with early Alzheimer's disease Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80284-7 |
0.399 |
|
| 2004 |
Craft S, Kulstad J, Green P, Cook D, Watson GS, Baker LD, Reger M, Cholerton B, Asthana S, Plymate S. O2-02-06 Insulin effects on plasma beta-amyloid levels in normal adults and patients with AD Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80116-7 |
0.331 |
|
| 2003 |
Cherrier MM, Craft S, Matsumoto AH. Cognitive changes associated with supplementation of testosterone or dihydrotestosterone in mildly hypogonadal men: a preliminary report. Journal of Andrology. 24: 568-576. PMID 12826696 DOI: 10.1002/J.1939-4640.2003.Tb02708.X |
0.334 |
|
| 2003 |
Watson GS, Peskind ER, Asthana S, Purganan K, Wait C, Chapman D, Schwartz MW, Plymate S, Craft S. Insulin increases CSF Abeta42 levels in normal older adults. Neurology. 60: 1899-903. PMID 12821730 DOI: 10.1212/01.Wnl.0000065916.25128.25 |
0.365 |
|
| 2003 |
Craft S, Asthana S, Cook DG, Baker LD, Cherrier M, Purganan K, Wait C, Petrova A, Latendresse S, Watson GS, Newcomer JW, Schellenberg GD, Krohn AJ. Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype. Psychoneuroendocrinology. 28: 809-22. PMID 12812866 DOI: 10.1016/S0306-4530(02)00087-2 |
0.385 |
|
| 2003 |
Cook DG, Leverenz JB, McMillan PJ, Kulstad JJ, Ericksen S, Roth RA, Schellenberg GD, Jin LW, Kovacina KS, Craft S. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele. The American Journal of Pathology. 162: 313-9. PMID 12507914 DOI: 10.1016/S0002-9440(10)63822-9 |
0.383 |
|
| 2003 |
Watson GS, Craft S. The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment. Cns Drugs. 17: 27-45. PMID 12467491 DOI: 10.2165/00023210-200317010-00003 |
0.376 |
|
| 2003 |
Ling X, Martins RN, Racchi M, Craft S, Helmerhorst E. Amyloid beta antagonizes insulin promoted secretion of the amyloid beta protein precursor. Journal of Alzheimer's Disease : Jad. 4: 369-74. PMID 12446969 DOI: 10.3233/Jad-2002-4504 |
0.324 |
|
| 2003 |
Aisen PS, Berg JD, Craft S, Peskind ER, Sano M, Teri L, Mulnard RA, Thomas RG, Thal LJ. Steroid-induced elevation of glucose in Alzheimer's disease: relationship to gender, apolipoprotein E genotype and cognition. Psychoneuroendocrinology. 28: 113-20. PMID 12445840 DOI: 10.1016/S0306-4530(02)00015-X |
0.396 |
|
| 2002 |
Cherrier MM, Anawalt BD, Herbst KL, Amory JK, Craft S, Matsumoto AM, Bremner WJ. Cognitive Effects of Short-Term Manipulation of Serum Sex Steroids in Healthy Young Men The Journal of Clinical Endocrinology and Metabolism. 87: 3090-3096. PMID 12107206 DOI: 10.1210/Jcem.87.7.8570 |
0.301 |
|
| 2001 |
Asthana S, Baker LD, Craft S, Stanczyk FZ, Veith RC, Raskind MA, Plymate SR. High-dose estradiol improves cognition for women with AD Results of a randomized study Neurology. 57: 605-612. PMID 11524467 DOI: 10.1212/Wnl.57.4.605 |
0.368 |
|
| 2001 |
Cherrier MM, Asthana S, Plymate S, Baker L, Matsumoto AM, Peskind E, Raskind MA, Brodkin K, Bremner W, Petrova A, LaTendresse S, Craft S. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology. 57: 80-8. PMID 11445632 DOI: 10.1212/Wnl.57.1.80 |
0.392 |
|
| 2000 |
Craft S, Asthana S, Schellenberg G, Baker L, Cherrier M, Boyt AA, Martins RN, Raskind M, Peskind E, Plymate S. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype. Annals of the New York Academy of Sciences. 903: 222-8. PMID 10818510 DOI: 10.1111/J.1749-6632.2000.Tb06371.X |
0.397 |
|
| 2000 |
Park CR, Seeley RJ, Craft S, Woods SC. Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiology & Behavior. 68: 509-14. PMID 10713291 DOI: 10.1016/S0031-9384(99)00220-6 |
0.325 |
|
| 2000 |
Boyt AA, Taddei TK, Hallmayer J, Helmerhorst E, Gandy SE, Craft S, Martins RN. The effect of insulin and glucose on the plasma concentration of Alzheimer's amyloid precursor protein. Neuroscience. 95: 727-34. PMID 10670439 DOI: 10.1016/S0306-4522(99)00458-3 |
0.346 |
|
| 2000 |
Craft S, Peskind E, Asthana S, Stennis Watson G, Baker LD, Cook DD, Schwartz MW. Effects of insulin on cerebrospinal fluid levels of Aβ42 Neurobiology of Aging. 21: 272. DOI: 10.1016/S0197-4580(00)83176-0 |
0.313 |
|
| 2000 |
Asthana S, Baker LD, Craft S, Cholerton BA, Gleason C, Stanzyck FZ, Raskind MA, Plymate SR. Neuroendocrine markers of cognition-enhancing efficacy of estrogen in postmenopausal women with Alzheimer's disease Neurobiology of Aging. 21: 92. DOI: 10.1016/S0197-4580(00)82640-8 |
0.385 |
|
| 2000 |
Baker LD, Asthana S, Gleason CE, Craft S, Cholerton BA, Watson GS, Ahmed SS. Raloxifene: Cognitive-enhancing effects for postmenopausal women with AD Neurobiology of Aging. 21: 92. DOI: 10.1016/S0197-4580(00)82639-1 |
0.379 |
|
| 2000 |
Watson GS, Baker LD, Asthana S, Peskind ER, Craft S. Insulin and cortisol effects of memory in Alzheimer's disease Neurobiology of Aging. 21: 92. DOI: 10.1016/S0197-4580(00)82637-8 |
0.365 |
|
| 2000 |
Cook DG, Craft S, Leverenz JB, Roth RA. Insulin degrading enzyme expression is reduced in hippocampus of Alzheimer's disease patients Neurobiology of Aging. 21: 120. DOI: 10.1016/S0197-4580(00)82339-8 |
0.335 |
|
| 2000 |
Cholerton BA, Baker LD, Gleason CE, Watson GS, Ahmed SS, Asthana S, Craft S. Early detection of cognitive decline in high functioning older adults Neurobiology of Aging. 21: 164. DOI: 10.1016/S0197-4580(00)82075-8 |
0.357 |
|
| 1999 |
Fucetola R, Newcomer JW, Craft S, Melson AK. Age- and dose-dependent glucose-induced increases in memory and attention in schizophrenia. Psychiatry Research-Neuroimaging. 88: 1-13. PMID 10641582 DOI: 10.1016/S0165-1781(99)00063-3 |
0.334 |
|
| 1999 |
Craft S, Asthana S, Newcomer JW, Wilkinson CW, Matos IT, Baker LD, Cherrier M, Lofgreen C, Latendresse S, Petrova A, Plymate S, Raskind M, Grimwood K, Veith RC. Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Archives of General Psychiatry. 56: 1135-1140. PMID 10591291 DOI: 10.1001/Archpsyc.56.12.1135 |
0.367 |
|
| 1999 |
Craft S, Asthana S, Schellenberg G, Cherrier M, Baker LD, Newcomer J, Plymate S, Latendresse S, Petrova A, Raskind M, Peskind E, Lofgreen C, Grimwood K. Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender. Neuroendocrinology. 70: 146-52. PMID 10461029 DOI: 10.1159/000054469 |
0.36 |
|
| 1999 |
Newcomer JW, Craft S, Fucetola R, Moldin SO, Selke G, Paras L, Miller R. Glucose-Induced Increase in Memory Performance in Patients With Schizophrenia Schizophrenia Bulletin. 25: 321-335. PMID 10416734 DOI: 10.1093/Oxfordjournals.Schbul.A033381 |
0.318 |
|
| 1999 |
Asthana S, Craft S, Baker LD, Raskind MA, Birnbaum RS, Lofgreen CP, Veith RC, Plymate SR. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease : results of a placebo-controlled, double-blind, pilot study Psychoneuroendocrinology. 24: 657-678. PMID 10399774 DOI: 10.1016/S0306-4530(99)00020-7 |
0.402 |
|
| 1998 |
Fanelli CG, Paramore DS, Hershey T, Terkamp C, Ovalle F, Craft S, Cryer PE. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes. 47: 1920-7. PMID 9836525 DOI: 10.2337/Diabetes.47.12.1920 |
0.38 |
|
| 1998 |
Ovalle F, Fanelli CG, Paramore DS, Hershey T, Craft S, Cryer PE. Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. Diabetes. 47: 1472-9. PMID 9726237 DOI: 10.2337/Diabetes.47.9.1472 |
0.302 |
|
| 1998 |
Craft S, Teri L, Edland SD, Kukull WA, Schellenberg G, McCormick WC, Bowen JD, Larson EB. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. Neurology. 51: 149-53. PMID 9674794 DOI: 10.1212/Wnl.51.1.149 |
0.396 |
|
| 1998 |
DeBaun MR, Schatz J, Siegel MJ, Koby M, Craft S, Resar L, Chu JY, Launius G, Dadash-Zadeh M, Lee RB, Noetzel M. Cognitive screening examinations for silent cerebral infarcts in sickle cell disease Neurology. 50: 1678-1682. PMID 9633710 DOI: 10.1212/Wnl.50.6.1678 |
0.305 |
|
| 1998 |
Newcomer JW, Craft S, Askins K, Hershey T, Bardgett ME, Csernansky JG, Gagliardi AE, Vogler G. Glucocorticoid interactions with memory function in schizophrenia. Psychoneuroendocrinology. 23: 65-72. PMID 9618753 DOI: 10.1016/S0306-4530(97)00081-4 |
0.359 |
|
| 1998 |
Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology. 50: 164-8. PMID 9443474 DOI: 10.1212/Wnl.50.1.164 |
0.385 |
|
| 1998 |
Craft S, Peskind E, Schwartz MW, Schellenberg GC, Raskind M, Porte D. Insulin, diabetes mellitus, Alzheimer's disease, and apolipoprotein E Neurology. 51: 926-926. DOI: 10.1212/Wnl.51.3.926 |
0.326 |
|
| 1998 |
DeBaun MR, Schatz J, Siegel M, Koby M, Craft S, Resar L, Chu JY, Launius G, Dadash-Zadeh M, Lee RB, Noetzel M. 620 Cognitive screening examination for silent cerebral infarcts in sickle cell anemia Journal of Pediatric Hematology Oncology. 20: 379. DOI: 10.1097/00043426-199807000-00057 |
0.328 |
|
| 1997 |
Hershey T, Craft S, Bhargava N, White NH. Memory and insulin dependent diabetes mellitus (IDDM): effects of childhood onset and severe hypoglycemia. Journal of the International Neuropsychological Society : Jins. 3: 509-20. PMID 9448364 DOI: 10.1017/S1355617797005092 |
0.303 |
|
| 1996 |
Craft S, Newcomer J, Kanne S, Dagogo-Jack S, Cryer P, Sheline Y, Luby J, Dagogo-Jack A, Alderson A. Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiology of Aging. 17: 123-30. PMID 8786794 DOI: 10.1016/0197-4580(95)02002-0 |
0.343 |
|
| 1996 |
Hvidberg A, Fanelli CG, Hershey T, Terkamp C, Craft S, Cryer PE. Impact of recent antecedent hypoglycemia on hypoglycemic cognitive dysfunction in nondiabetic humans. Diabetes. 45: 1030-6. PMID 8690148 DOI: 10.2337/Diab.45.8.1030 |
0.388 |
|
| 1996 |
Craft S, Asthana S, Tio-Matos I, Hunter E, Lofgreen C, Newcomer J, Aaskind M, Wilkinson C, Veith R, Plymate S, Gibson L, Latendresse S. 289 Hyperinsulinemia improves memory in Alzheimer's disease Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80291-0 |
0.331 |
|
| 1995 |
Craft S, Park TS, White DA, Schatz J, Noetzel M, Arnold S. Changes in cognitive performance in children with spastic diplegic cerebral palsy following selective dorsal rhizotomy. Pediatric Neurosurgery. 23: 68-74; discussion 75. PMID 8555098 DOI: 10.1159/000120939 |
0.328 |
|
| 1994 |
Newcomer JW, Craft S, Hershey T, Askins K, Bardgett ME. Glucocorticoid-induced impairment in declarative memory performance in adult humans. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 2047-53. PMID 8198631 DOI: 10.1523/Jneurosci.14-04-02047.1994 |
0.319 |
|
| 1994 |
Craft S, Murphy C, Wemstrom J. Glucose effects on complex memory and nonmemory tasks: The influence of age, sex, and glucoregulatory response Psychobiology. 22: 95-105. DOI: 10.3758/Bf03327086 |
0.304 |
|
| 1993 |
Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. Journal of Clinical Investigation. 91: 819-828. PMID 8450063 DOI: 10.1172/Jci116302 |
0.305 |
|
| 1993 |
Craft S, Dagogo-Jack SE, Wiethop BV, Murphy C, Nevins RT, Fleischman S, Rice V, Newcomer JW, Cryer PE. Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. Behavioral Neuroscience. 107: 926-940. PMID 8136068 DOI: 10.1037//0735-7044.107.6.926 |
0.368 |
|
| 1992 |
Craft S, Zallen G, Baker LD. Glucose and memory in mild senile dementia of the alzheimer type Journal of Clinical and Experimental Neuropsychology. 14: 253-267. PMID 1572948 DOI: 10.1080/01688639208402827 |
0.32 |
|
| 1991 |
Hirsch IB, Boyle PJ, Craft S, Cryer PE. Higher glycemic thresholds for symptoms during beta-adrenergic blockade in IDDM. Diabetes. 40: 1177-86. PMID 1657673 DOI: 10.2337/Diab.40.9.1177 |
0.301 |
|
| Show low-probability matches. |